DK1448220T3 - Farmaceutisk middel indeholdende et antiflogistisk virksomt stof og lactalbuminhydrolysat og anvendelse deraf - Google Patents

Farmaceutisk middel indeholdende et antiflogistisk virksomt stof og lactalbuminhydrolysat og anvendelse deraf

Info

Publication number
DK1448220T3
DK1448220T3 DK02792816T DK02792816T DK1448220T3 DK 1448220 T3 DK1448220 T3 DK 1448220T3 DK 02792816 T DK02792816 T DK 02792816T DK 02792816 T DK02792816 T DK 02792816T DK 1448220 T3 DK1448220 T3 DK 1448220T3
Authority
DK
Denmark
Prior art keywords
antiflogistically
active substance
agent containing
pharmaceutical agent
lactalbumin hydrolyzate
Prior art date
Application number
DK02792816T
Other languages
Danish (da)
English (en)
Inventor
Martin Goerne
Original Assignee
Exalation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Exalation Ltd filed Critical Exalation Ltd
Application granted granted Critical
Publication of DK1448220T3 publication Critical patent/DK1448220T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
    • A61K38/018—Hydrolysed proteins; Derivatives thereof from animals from milk
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
DK02792816T 2001-11-27 2002-11-27 Farmaceutisk middel indeholdende et antiflogistisk virksomt stof og lactalbuminhydrolysat og anvendelse deraf DK1448220T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10158039A DE10158039A1 (de) 2001-11-27 2001-11-27 Antiphlogistisches Mittel und dessen Verwendung
PCT/EP2002/013385 WO2003045416A2 (fr) 2001-11-27 2002-11-27 Agent antiphlogistique et son utilisation

Publications (1)

Publication Number Publication Date
DK1448220T3 true DK1448220T3 (da) 2008-11-03

Family

ID=7707054

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02792816T DK1448220T3 (da) 2001-11-27 2002-11-27 Farmaceutisk middel indeholdende et antiflogistisk virksomt stof og lactalbuminhydrolysat og anvendelse deraf

Country Status (10)

Country Link
US (1) US20050054556A1 (fr)
EP (1) EP1448220B1 (fr)
AT (1) ATE400286T1 (fr)
AU (1) AU2002358551A1 (fr)
CY (1) CY1108402T1 (fr)
DE (2) DE10158039A1 (fr)
DK (1) DK1448220T3 (fr)
ES (1) ES2309221T3 (fr)
PT (1) PT1448220E (fr)
WO (1) WO2003045416A2 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070190130A1 (en) * 2006-02-16 2007-08-16 Mark William A Protein hydrolysate excipients

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1029660A (fr) * 1973-06-01 1978-04-18 Kyowa Hakko Kogyo Co. Prevention des lesions gastriques
JPH0732718B2 (ja) * 1985-01-18 1995-04-12 クマ−ル ガウリ，カイラツシユ 蛋白加水分解物およびその製造法
EP0326618A1 (fr) * 1987-03-04 1989-08-09 Nippon Hypox Laboratories Incorporated Composition medicinale contenant de l'albumine en tant que support et procede de preparation
CA1324083C (fr) * 1987-03-09 1993-11-09 Tetsu Miyoshi Preparations pharmaceutiques renfermant des anti-inflammatoires non steroidiens
AU3860797A (en) * 1997-07-16 1999-02-10 Antrin Research Limited Pharmaceutical formulations for oral administration

Also Published As

Publication number Publication date
EP1448220A2 (fr) 2004-08-25
ATE400286T1 (de) 2008-07-15
US20050054556A1 (en) 2005-03-10
DE10158039A1 (de) 2003-07-03
ES2309221T3 (es) 2008-12-16
DE50212485D1 (de) 2008-08-21
WO2003045416A3 (fr) 2003-12-24
CY1108402T1 (el) 2014-02-12
PT1448220E (pt) 2008-10-15
AU2002358551A1 (en) 2003-06-10
EP1448220B1 (fr) 2008-07-09
AU2002358551A8 (en) 2003-06-10
WO2003045416A2 (fr) 2003-06-05

Similar Documents

Publication Publication Date Title
NO20053077L (no) Terapeutiske formuleringer for behandling av beta-amyloid-relaterte sykdommer.
EE03473B1 (et) Prootonpumba inhibiitorit sisaldav farmatseutiline kompositsioon
HUP0104718A2 (hu) Mikronizált eplerenon kompozíciók és eljárás az előállításukra
NO20100061L (no) Forhindring og behandling av amyloidogen sykdom
DE60332358D1 (de) Protease-resistente modifizierte interferon alpha polypeptide
ATE204178T1 (de) Methode zur behandlung und vorbeugung von typ-1 diabetis durch orale verabreichung von insulin
HUP0101017A2 (hu) Készítmény és eljárás szájon át adagolható vakcinák és gyógyászati hatóanyagok szisztémás bevitelére
HUP0301349A2 (hu) IL-11-tartalmú készítmények
HUP0002247A2 (hu) Proteáz inhibitorok
ES2168457T3 (es) Composiciones farmaceuticas que comprenden una superoxido dismutasa.
NO972391L (no) 2-substituerte 1,2,5-tiadiazolidin-3-on 1,1-dioksider og preparater og metoder for anvendelse derav
SE9801495D0 (sv) Protein formulationa
DK0988043T3 (da) Fremstillingsmåde og produkt, hvori der anvendes størnotochord til lindring af artritissymptomer
EA199700381A1 (ru) Диароматические соединения пропинила или диенила, промежуточные соединения, фармацевтические и косметические композиции на основе указанных соединений и применение косметических композиций
DK1343472T3 (da) Thixotropisk næsespray
DE60322064D1 (de) 4,4' -dithiobis- (3-aminobutane-1-sulfonate)-derivate und sie enthaltende zusammensetzungen
DK1448220T3 (da) Farmaceutisk middel indeholdende et antiflogistisk virksomt stof og lactalbuminhydrolysat og anvendelse deraf
NO995838L (no) Nye heteroetynylenforbindelser og farmasoeytiske og kosmetiske preparater inneholdende de samme
DK1492539T3 (da) Statin-terapi til forögelse af kognitiv funktion
DK1448219T3 (da) Antiglaukomatöst middel og anvendelse deraf
SE9902936D0 (sv) Pharmaceutical compositions
ATE189395T1 (de) Verwendung von protease nexin-i als mittel gegen entzündungen
SE9904132D0 (sv) Pharmaceutical composition for treatment of diarrhea
TR200202110T2 (tr) "5-[{6-(2-Flüore benzil) oksi-2-naftil}metil]-2,4-tiyazolidin dion kristalleri"
DE69630948T2 (de) Peptide und medikamente für knochenkrankheiten welche diese peptide als aktive bestandteile beinhalten